In particular, a tumor suppressor activity was demonstrated in esophageal tumors [33], as well as in colorectal and gastric cancer [34, 35], while an intense MAL protein expression was detected in specific types of renal carcinoma and in thyroid follicular cell-derived carcinoma [36]. The gene discussed is MAL; the disease is gastric cancer.